No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO)
Maarten Beekman(The Netherlands Cancer Institute), Angela H.E.M. Maas(Radboud University Nijmegen), B.F.M. Slangen(Maastricht University Medical Centre), Lara Terra(The Netherlands Cancer Institute), Joanne A. de Hullu(Radboud University Nijmegen), E.B.L. van Dorst(Radboud University Nijmegen), Bernadette A. M. Heemskerk‐Gerritsen(Erasmus MC), Flora E. van Leeuwen(The Netherlands Cancer Institute), Jeanine E. Roeters van Lennep(Erasmus MC), Marc van Beurden(Oncode Institute), Lieke P. V. Berger(University Medical Center Groningen), Constantijne H. Mom, Helena C. van Doorn, Maartje J. Hooning(Erasmus MC Cancer Institute), Klaartje van Engelen(Amsterdam UMC Location University of Amsterdam), Marijke R. Wevers(Radboud University Nijmegen), J. Margriet Collée(Erasmus MC Cancer Institute), Lizet E. van der Kolk(The Netherlands Cancer Institute), Margreet G E M Ausems(University Medical Center Utrecht), Katja N. Gaarenstroom(Leiden University Medical Center), E. Gómez(Maastricht University Medical Centre), Christi J. van Asperen(Leiden University Medical Center), Marian J.E. Mourits(Radboud University Nijmegen)
Cited by 2
Related Papers
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
|JAMA|2003|659
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
|Cancer Treatment Reviews|2016|616
Health Council of the Netherlands: No need to change from SAR to time-temperature relation in electromagnetic fields exposure limits
|International Journal of Hyperthermia|2011|606
Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years
|Journal of Clinical Oncology|2002|564